Q&A With Sophie Megnien From Genfit: Work Progressing On New Nonalcoholic Steatohepatitis Treatment

While there are currently no approved treatments for nonalcoholic steatoheptitis there are medications working their way through the approval process including at least a few in phase III studies.

One of the companies working on bringing this new treatment to the market is Genfit whose Chief Medical Officer Sophie Megnien talked about what this could mean for patients during the annual Liver meeting in San Francisco.